Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Dako Launches Two Ready-to-Use Antibodies for Cancer Diagnosis
Wednesday, May 07, 2014
Company announces addition of Anti-CK 8/18 and Anti-TdT antibodies for routine diagnostic use.

Flexible Forward Scatter Technology Enables Advances
Thursday, May 01, 2014
MoFlo® Astrios EQ from Beckman Coulter Life Sciences Delivers Simultaneous High-speed Cell Sorting and Sub-micron Particle Detection.

Molecular Devices Introduces Microplate Reader and Washer
Monday, April 28, 2014
The inexpensive and versatile EMax® Plus Microplate Reader and MultiWash™+ Microplate Washer are designed for labs just starting up or looking to extend capabilities with affordable, yet reliable instrumentation that utilizes the industry-standard SoftMax® Pro Microplate Data Acquisition and Analysis Software.

New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.

New Monoclonal Antibodies to Mumps Virus
Friday, April 18, 2014
3 New monoclonal antibodies function in ELISA and IFA.

Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.

Hevylite® FDA Cleared to Help Monitor Patients with IgG and IgA Myeloma
Friday, April 11, 2014
Hevylite® measures the concentration of each immunoglobulin subtype.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

AB SCIEX Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients
Friday, April 04, 2014
The SCIEX IVD-MS™ Immunosuppressants kit is designed to give clinicians fast, accurate information about the level of immunosuppressant drug circulating in a patient’s body.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 362
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv